Risk stratification of sudden cardiac death: a review

Jacob Tfelt-Hansen*, Rodrigue Garcia, Christine Albert, Jose Merino, Andrew Krahn, Eloi Marijon, Cristina Basso, Arthur A.M. Wilde, Kristina Hermann Haugaa

*Corresponding author for this work

Research output: Contribution to journalReviewResearchpeer-review

23 Citations (Scopus)
12 Downloads (Pure)

Abstract

Sudden cardiac death (SCD) is responsible for several millions of deaths every year and remains a major health problem. To reduce this burden, diagnosing and identification of high-risk individuals and disease-specific risk stratification are essential. Treatment strategies include treatment of the underlying disease with lifestyle advice and drugs and decisions to implant a primary prevention implantable cardioverter-defibrillator (ICD) and perform ablation of the ventricles and novel treatment modalities such as left cardiac sympathetic denervation in rare specific primary electric diseases such as long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. This review summarizes the current knowledge on SCD risk according to underlying heart disease and discusses the future of SCD prevention.

Bibliographical note

Publisher Copyright:
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Keywords

  • Cardiomyopathy
  • Ischaemic heart disease
  • Primary electric disease
  • Risk
  • SCD

Cite this